↓ Skip to main content

Improving the understanding of how patients with non-dystrophic myotonia are selected for myotonia treatment with mexiletine (NaMuscla): outcomes of treatment impact using a European Delphi panel

Overview of attention for article published in BMC Neurology, December 2021
Altmetric Badge

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
18 Mendeley